Steglujan
Payments companies reported to CMS as associated with Steglujan. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Steglujan, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Steglujan
These are the largest totals companies reported as associated with Steglujan. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Wilson Sze | Humble, TX | Endocrinology, Diabetes & Metabolism | $118.39 |
| Mark Hodges | Washington Court House, OH | Internal Medicine | $115.01 |
| Wuhua Jing | New York, NY | Internal Medicine | $104.19 |
| Marc Legris | Norwalk, CT | Internal Medicine | $100.07 |
| Andres Nisimblat | Corpus Christi, TX | Family Medicine | $98.67 |
| Pamela Smith | Corpus Christi, TX | Internal Medicine | $98.67 |
| Stuart Weiss | New York, NY | Endocrinology, Diabetes & Metabolism | $94.01 |
| Arthur Mcdermet | Pennsauken, NJ | Family Medicine | $93.79 |
| Robert Lingle | Humble, TX | Cardiovascular Disease | $86.88 |
| Wayne Woo | Flowood, MS | Endocrinology, Diabetes & Metabolism | $86.55 |
Prescribed Steglujan?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.